Literature DB >> 24928064

Expression of claudin-3 in the esophagus and larynx of rat reflux model.

Xiao Bing Xu1, Ying Hu2, Yang Wang3, Chui Jin Lai3, Tian Yu Zhang1.   

Abstract

OBJECTIVE: The aim of this study was to investigate the association between laryngeal expression of claudin-3 and laryngopharyngeal reflux (LPR) in a rat reflux model.
METHODS: Eight Wistar rats were divided into two groups. Four rats underwent total esophageal myectomy to induce reflux, and the remainder underwent a sham operation as a control. All animals were sacrificed 12 weeks after surgery to perform tissue histology and Western blot analysis.
RESULTS: Lymphocyte infiltration increased significantly in the study group in both esophageal and laryngeal samples (P=0.001, 0.002, respectively). Both esophageal and laryngeal expressions of claudin-3 were significantly lower in the study group when compared with that in the control group (P=0.045, 0.037, respectively).
CONCLUSION: The results of this study suggest that a decrease in claudin-3 could be a sensitive indicator of reflux laryngitis in rats.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Claudin-3; Gastroesophageal reflux disease; Laryngopharyngeal reflux

Mesh:

Substances:

Year:  2014        PMID: 24928064     DOI: 10.1016/j.anl.2014.05.011

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  2 in total

1.  Additive Effects of Rebamipide Plus Proton Pump Inhibitors on the Expression of Tight Junction Proteins in a Rat Model of Gastro-Esophageal Reflux Disease.

Authors:  Tae-Geun Gweon; Jong-Hyung Park; Byung-Wook Kim; Yang Kyu Choi; Joon Sung Kim; Sung Min Park; Chang Whan Kim; Hyung-Gil Kim; Jun-Won Chung
Journal:  Gut Liver       Date:  2018-01-15       Impact factor: 4.519

2.  Acute Acrolein Exposure Induces Impairment of Vocal Fold Epithelial Barrier Function.

Authors:  Xinxin Liu; Wei Zheng; M Preeti Sivasankar
Journal:  PLoS One       Date:  2016-09-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.